JORDEN DAVID EMERSON (CEO, CFO) received a stock award from NUO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/2/2022ACC: 0001437749-22-010382
DirectorOfficer· CEO, CFO
Since Aug 2018
+10.53K
Net shares
Net buyer
$10.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
10.53K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.53K
Price / share
$1.00
Trade value
$10.53K
% of position
0.5%
4/29/2022
2.13M→2.14M
Total
Net shares
+10.53K
Net value
$10.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/29/2022 | A · Award | +10.53K | $1.00 | $10.53K | 0.5% | 2.13M | 2.14M |
| Total | +10.53K | $10.53K | ||||||
Derivative Transactions0
No derivative transactions reported